CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Serge Saxonov

Co-Founder and Chief Executive Officer, 10x Genomics, Inc.

Search every verified Serge Saxonov interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Serge Saxonov, co-founder and CEO of 10x Genomics, discussed the company's growth and the broader impact of single-cell analysis in a 2019 podcast interview. He described the company's commercial revenue trajectory, reporting $3 million in 2015, $28 million in 2016, $71 million in 2017, and $146 million in 2018. Saxonov characterized the scaling as rapid and attributed the company's success to its focus on building a large, meaningful company, noting that an initial public offering was possible but would be pursued only as a means to support that goal. Regarding the field of genomics, Saxonov emphasized that the shift toward single-cell analysis involves analyzing individual cells in parallel from tissue samples, rather than focusing on a single cell or analyzing tissue in bulk. He stressed the importance of throughput and scale in enabling researchers to obtain gene expression profiles across many individual cells, which he framed as a fundamental change in how biological experiments are conducted.

Recent appearances

  • From Single Cell to Atera: The Future of Biology Measured at Scale - Serge Saxonov, CEO 10x Genomics

    In this episode of Diagnosing Dx, I’m joined by Serge Saxonov, Co-founder and CEO of 10x Genomics, a leader in single cell and spatial biology. Serge shares the story behind 10x Genomics, the evolution of its foundational technologies, and the launch of Atera, a new platform designed to enable whole transcriptome analysis in tissue at scale with single cell level sensitivity. We explore why biology has been fundamentally limited by the way we measure it, what changes when those constraints are removed, and how better tools can open up entirely new possibilities for discovery and precision me…

    Watch on YouTube ↗

  • 10x Genomics Q4 2025 Earnings Call

    10x Genomics Q4 2025 Earnings Conference Call. If you find our work useful, please support us by purchasing a Super Thanks— it truly helps us a lot. #earningscall #StockMarketNews #conferenceCall Earnings Call | Earnings Conference Call | Earnings concall | concall | quarterly results | Stock News | Full Year results | Fiscal Year results | investment news | stock latest news If you want us to remove your company's earnings call or any other conference call, please reach out to [email protected].

    Watch on YouTube ↗

  • AI, Single Cell Biology, and the Inflection Point in Cancer Research

    Cancer research is at a rare inflection point. In this conversation, Alicia Zhou, PhD, and Serge Saxonov, PhD, explain how breakthroughs in AI, large language models, single-cell sequencing, and spatial biology are converging at the same moment. Together, these advances make it possible to measure biology at scale—and turn that data into real insight. This clip explores why the tools, the data, and the scientific questions have finally aligned to enable a step-change in immunotherapy discovery. -- Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization de…

    Watch on YouTube ↗

  • Transforming Drug Discovery and Disease Research—One Cell at a Time

    The ARC Virtual Cell Atlas uses high-throughput single-cell genomics, artificial intelligence, and open science to understand the complexities of cellular behavior. Developed through a partnership between the ARC Institute, 10x Genomics, and Ultima Genomics, the public domain resource integrates data from hundreds of millions of cells. By curating and harmonizing vast amounts of single-cell measurements, the Atlas paves the way for virtual cell simulations that can predict how cells respond to genetic or chemical changes. These models hold the promise for transforming drug discovery by acceler…

    Watch on YouTube ↗

  • Ep40: Serge Saxonov

    Serge Saxonov on the single-cell analysis revolution.

    Watch on YouTube ↗

  • 10x Genomics toolkit ‘at the fulcrum of innovation,’ CEO says

    #Genomics #yahoofinance #biotech This segment originally aired on January 10, 2023. 10x Genomics CEO Serge Saxonov joins Yahoo Finance live anchor Rachell Akuffo to discuss biotechnology innovation, progress in genomics, and macroeconomic headwinds. Don't Miss: Valley of Hype: The culture that built Elizabeth Holmes WATCH HERE:    • Elizabeth Holmes: 'Valley of Hype' [pre-sh...   Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction…

    Watch on YouTube ↗

  • 10X Genomics Inc Q3 2022 Earnings Call

    Access earnings conference call transcripts at: https://news.alphastreet.com/earnings... Earnings Infographics: https://news.alphastreet.com/infograp... Earnings Calendar: https://news.alphastreet.com/earnings... CEO Interviews: https://news.alphastreet.com/interviews/ Listen on: https://podcasts.apple.com/us/podcast... https://anchor.fm/earningspodcast/ https://open.spotify.com/show/67gyUX6... https://podcasts.google.com/feed/aHR0... https://radiopublic.com/the-earnings-... Follow us on:   / alphst_live     / _alphastreet     / alphastreetinc     / alphastreet   http://www.google.com/news…

    Watch on YouTube ↗

  • Founder Stories: Serge Saxonov, Co-Founder and CEO of 10X Genomics

    Serge Saxonov co-founded 10x Genomics in 2012. As the CEO, he defined the 10x vision and strategy, contributed to core inventions, and has led the company since inception. Prior to 10x Genomics, Serge was Vice President of Applications at QuantaLife, where he built products and defined the company’s growth areas. Serge was the first employee at 23andMe, where he served as Founding Architect and Director of R&D. There he defined the initial concept of the product, built out the core technology, and drove strategy and execution of R&D functions. Serge received a Ph.D. in biomedical informatics f…

    Watch on YouTube ↗

  • TXG Stock | 10X Genomics Inc Q1 2022 Earnings Call

    Access earnings conference call transcripts at: https://news.alphastreet.com/earnings... Earnings Infographics: https://news.alphastreet.com/infograp... Earnings Calendar: https://news.alphastreet.com/earnings... CEO Interviews: https://news.alphastreet.com/interviews/ Listen on: https://podcasts.apple.com/us/podcast... https://anchor.fm/earningspodcast/ https://open.spotify.com/show/67gyUX6... https://podcasts.google.com/feed/aHR0... https://radiopublic.com/the-earnings-... Follow us on:   / alphst_live     / _alphastreet     / alphastreetinc     / alphastreet   http://www.google.com/news…

    Watch on YouTube ↗

  • TXG Stock | 10X Genomics Inc Q4 2021 Earnings Call

    Access earnings conference call transcripts at: https://news.alphastreet.com/earnings... Earnings Infographics: https://news.alphastreet.com/infograp... Earnings Calendar: https://news.alphastreet.com/earnings... CEO Interviews: https://news.alphastreet.com/interviews/ Listen on: https://podcasts.apple.com/us/podcast... https://anchor.fm/earningspodcast/ https://open.spotify.com/show/67gyUX6... https://podcasts.google.com/feed/aHR0... https://radiopublic.com/the-earnings-... Follow us on:   / alphst_live     / _alphastreet     / alphastreetinc     / alphastreet   http://www.google.com/news…

    Watch on YouTube ↗

  • 10X Genomics Strategy Driven By Innovation, CEO Says

    Jan.12 -- 10X Genomics Inc. Chief Executive Officer Serge Saxonov discusses the company's strategy and performance amid the Covid-19 pandemic with Bloomberg's Vonnie Quinn on "Bloomberg Markets."

    Watch on YouTube ↗

  • 10x Genomics, Inc TXG CEO Serge Saxonov On Q3 2020 Results

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →